Narcity Canada on MSN
Canada Pension Plan payments for December 2025 are going out early — Here's when & how much
December is rolling right along, and if you count on monthly government payments like the Canada Pension Plan, there's an ...
Amazon Q Developer is a useful AI-powered coding assistant with chat, CLI, Model Context Protocol and agent support, and AWS ...
The Godfather Part ii (1974) Few lines in cinema are as iconic as this one from Michael Corleone. It’s spoken during a moment ...
Social Security COLA increase in 2026 may hike SSA and SSI payments but still not benefit you because higher Medicare ...
ActionAdventureTwins on MSN
This old mine felt like it could collapse at any moment
This underground soapstone mine looks unreal the moment you step inside, with massive green and blue walls opening into huge ...
In addition to contributing to the growth of the Trust's private capital partnerships, the Transaction is a continuation of the Trust's ongoing capital recycling strategy. Since 2019, the Trust ...
This matters, because institutional investors care a lot about their risk-adjusted returns, and many will use leverage to scale up investment into lower-volatility assets so as to maintain the overall ...
Social Security faces trust fund depletion by 2034, threatening benefits for millions of retirees. The CRFB proposes a COLA ...
Narcity Canada on MSN
Old Age Security payments for December are arriving early — Here's when & how much
The holiday countdown is on, and that means another round of government payments is headed to Canadians across the country, ...
Canadian Solar Inc. (the "Company" or "Canadian Solar") today announced that e-STORAGE, part of the Company's majority-owned subsidiary CSI Solar Co., Ltd. ("CSI Solar"), will deliver 408 MWh AC ...
ALLETE, Inc. (NYSE: ALE) (the Company) today announced the completion of its acquisition by Canada Pension Plan Investment Board (CPP Investments) and Global Infrastructure Partners (GIP), following ...
Foresee Pharmaceuticals (TPEx: 6576), ("Foresee") today announced positive topline results from its Phase 3 Casppian clinical trial evaluating the efficacy and safety of FP-001 42 mg (leuprolide ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results